Jens Pietzsch Selected Research

Jens Pietzsch Research Topics

Disease

81	Neoplasms (Cancer) 03/2024 - 12/2004
24	Melanoma (Melanoma, Malignant) 01/2022 - 11/2009
15	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2009
11	Pheochromocytoma 01/2024 - 11/2014
10	Inflammation (Inflammations) 01/2023 - 03/2009
8	Paraganglioma (Paragangliomas) 01/2024 - 10/2018
7	Hypoxia (Hypoxemia) 01/2022 - 08/2007
5	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 01/2007
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2024 - 11/2014
5	Carcinoma (Carcinomatosis) 05/2023 - 12/2007
5	Colonic Neoplasms (Colon Cancer) 01/2023 - 12/2004
5	Atherosclerosis 01/2016 - 10/2002
5	Glucose Intolerance 01/2009 - 10/2002
4	Carcinogenesis 01/2020 - 02/2008
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2018 - 12/2004
3	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 05/2017
3	Disease Progression 01/2024 - 11/2014
3	Adenocarcinoma 09/2020 - 12/2007
3	Leukemia 01/2018 - 01/2017
3	Acute Lung Injury 01/2018 - 01/2015
3	Type 2 Diabetes Mellitus (MODY) 01/2009 - 10/2002
2	Fibrosarcoma 03/2024 - 11/2020
2	Glioma (Gliomas) 01/2024 - 11/2023
2	Infections 01/2023 - 10/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 10/2002
2	Pain (Aches) 07/2022 - 12/2016
2	Tumor Lysis Syndrome 01/2019 - 01/2018
2	Brain Neoplasms (Brain Tumor) 03/2018 - 12/2004
2	Lung Injury 07/2015 - 01/2015

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2007
12	Peptides (Polypeptides)IBA 07/2023 - 01/2012
9	AntigensIBA 03/2024 - 01/2017
9	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2023 - 01/2013
9	oxidized low density lipoproteinIBA 01/2016 - 10/2002
7	LigandsIBA 03/2024 - 01/2010
7	Radioisotopes (Radionuclides)IBA 01/2024 - 02/2014
7	Phosphotransferases (Kinase)IBA 11/2020 - 03/2012
6	CatecholaminesIBA 01/2023 - 11/2014
6	EnzymesIBA 01/2022 - 12/2013
6	S100 Proteins (S 100 Protein)IBA 05/2016 - 02/2008
5	CytokinesIBA 01/2023 - 12/2017
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2012
5	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 10/2022 - 01/2013
4	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2024 - 01/2016
4	Tyrosine (L-Tyrosine)FDA Link 10/2022 - 11/2012
4	EphA1 Receptor (Eph Receptor)IBA 01/2020 - 03/2012
4	Chimeric Antigen ReceptorsIBA 01/2018 - 01/2017
4	Amino Acids FDA Link 01/2017 - 12/2004
4	Eph Family Receptors (Eph Receptors)IBA 01/2017 - 01/2010
4	Receptor for Advanced Glycation End ProductsIBA 05/2016 - 02/2008
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2016 - 04/2003
4	Glucose (Dextrose)FDA LinkGeneric 11/2009 - 10/2002
3	Lysine (L-Lysine)FDA Link 03/2024 - 11/2017
3	Somatostatin Receptors (Somatostatin Receptor)IBA 07/2023 - 01/2016
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2023 - 01/2016
3	EpitopesIBA 01/2023 - 01/2018
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2023 - 05/2019
3	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2023 - 05/2019
3	RadiopharmaceuticalsIBA 01/2022 - 10/2017
3	Cytostatic AgentsIBA 01/2020 - 01/2019
3	Messenger RNA (mRNA)IBA 05/2019 - 08/2007
3	Dopamine (Intropin)FDA LinkGeneric 04/2019 - 11/2014
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2019 - 11/2014
3	Melanocyte-Stimulating Hormones (MSH)IBA 01/2019 - 03/2016
3	LipidsIBA 01/2019 - 04/2003
3	Cetuximab (Erbitux)FDA Link 10/2018 - 02/2014
3	ErbB Receptors (EGF Receptor)IBA 10/2018 - 03/2014
3	AcidsIBA 01/2018 - 01/2015
3	Calcium-Binding ProteinsIBA 05/2016 - 10/2011
3	EphrinsIBA 04/2013 - 01/2010
2	bispidineIBA 03/2024 - 11/2022
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2024 - 11/2023
2	Capsules (Microcapsules)IBA 01/2024 - 06/2023
2	AlginatesIBA 06/2023 - 03/2010
2	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 01/2018
2	ProdrugsIBA 01/2023 - 05/2019
2	Celecoxib (Celebrex)FDA Link 10/2022 - 01/2019
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2022 - 01/2022
2	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2022 - 01/2018
2	IsoenzymesIBA 01/2022 - 10/2020
2	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2018
2	fluoromisonidazoleIBA 01/2022 - 04/2013
2	Selective Estrogen Receptor Modulators (SERM)IBA 01/2022 - 01/2019
2	GhrelinIBA 03/2021 - 04/2012
2	endothelial PAS domain-containing protein 1IBA 01/2021 - 05/2019
2	pyrimidineIBA 11/2020 - 06/2010
2	EstersIBA 05/2019 - 02/2015
2	Diphosphonates (Bisphosphonates)IBA 01/2019 - 12/2016
2	Type 1 Melanocortin ReceptorIBA 01/2019 - 03/2016
2	NormetanephrineIBA 10/2018 - 11/2014
2	3-methoxytyramine (methoxytyramine)IBA 10/2018 - 11/2014
2	LuciferasesIBA 10/2018 - 11/2017
2	Chelating AgentsIBA 10/2018 - 07/2017
2	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 10/2018 - 01/2017
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 09/2015
2	Erythropoietin FDA Link 09/2015 - 09/2014

Therapy/Procedure

23	Therapeutics 01/2024 - 02/2008
14	Precision Medicine 01/2024 - 03/2014
5	Radiotherapy 01/2021 - 01/2014
2	Aftercare (After-Treatment) 01/2016 - 11/2009